Page last updated: 2024-11-02

papaverine and Autoimmune Diseases

papaverine has been researched along with Autoimmune Diseases in 1 studies

Papaverine: An alkaloid found in opium but not closely related to the other opium alkaloids in its structure or pharmacological actions. It is a direct-acting smooth muscle relaxant used in the treatment of impotence and as a vasodilator, especially for cerebral vasodilation. The mechanism of its pharmacological actions is not clear, but it apparently can inhibit phosphodiesterases and it may have direct actions on calcium channels.
papaverine : A benzylisoquinoline alkaloid that is isoquinoline substituted by methoxy groups at positions 6 and 7 and a 3,4-dimethoxybenzyl group at position 1. It has been isolated from Papaver somniferum.

Autoimmune Diseases: Disorders that are characterized by the production of antibodies that react with host tissues or immune effector cells that are autoreactive to endogenous peptides.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Ručilová, V1
Świerczek, A1
Vanda, D1
Funk, P1
Lemrová, B1
Gawalska, A1
Bucki, A1
Nowak, B1
Zadrożna, M1
Pociecha, K1
Soural, M1
Wyska, E1
Pawłowski, M1
Chłoń-Rzepa, G1
Zajdel, P1

Other Studies

1 other study available for papaverine and Autoimmune Diseases

ArticleYear
New imidazopyridines with phosphodiesterase 4 and 7 inhibitory activity and their efficacy in animal models of inflammatory and autoimmune diseases.
    European journal of medicinal chemistry, 2021, Jan-01, Volume: 209

    Topics: Animals; Anti-Inflammatory Agents; Autoimmune Diseases; Cyclic Nucleotide Phosphodiesterases, Type 7

2021